Christine Swenson is a forward-thinking global regulatory affairs professional with extensive clinical development experience. Her career spans more than thirty years of drug development, including extensive leadership of domestic and international regulatory affairs, across early- and clinical-stage development of both biologics and small molecules for multiple therapeutic areas. Christine was Senior Vice President, Global Regulatory Affairs at Laronde and Senior Vice President at Beam, as well as Vice President, Global Regulatory Affairs at Moderna, where she led the development and execution of regulatory strategies for its portfolio of mRNA therapeutics and vaccines. Prior to Moderna, she held leadership roles in regulatory affairs, which included global regulatory lead for the Yervoy and Opdivo immuno-oncology programs at Bristol-Myers Squibb, Adnexus, ImmunoGen and Coley Pharmaceutical Group. Christine received a Bachelor of Science in Biology from Stonehill College